Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

HIV and the liver

Work during the past two decades has highlighted how HIV contributes to hepatic inflammation and fibrosis, leading to changes in the timing of antiretroviral therapy initiation and to improved diagnosis and management of liver disease in patients with HIV. As this population ages, clinician vigilance with early detection of emerging liver disease will be critical.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Promotion of hepatic inflammation and fibrosis by HIV in chronic liver disease.


  1. Benhamou, Y. et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30, 1054–1058 (1999).

    CAS  Article  Google Scholar 

  2. Puoti, M. et al. Natural history of chronic hepatitis B in co-infected patients. J. Hepatol. 44, S65–S70 (2006).

    Article  Google Scholar 

  3. Tuyama, A. C. et al. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 52, 612–622 (2010).

    CAS  Article  Google Scholar 

  4. Weber, R. et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch. Intern. Med. 166, 1632–1641 (2006).

    Article  Google Scholar 

  5. INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N. Engl. J. Med. 373, 795–807 (2015).

    Article  Google Scholar 

  6. Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365–1371 (2006).

    CAS  Article  Google Scholar 

  7. Wallet, M. A. et al. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T cell activation following therapy. AIDS 24, 1281–1290 (2010).

    CAS  Article  Google Scholar 

  8. Mosoian, A. et al. Frontline science: HIV infection of Kupffer cells results in an amplified proinflammatory response to LPS. J. Leukoc. Biol. 101, 1083–1090 (2017).

    CAS  Article  Google Scholar 

  9. Balagopal, A. et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 135, 226–233 (2008).

    CAS  Article  Google Scholar 

  10. Lemoine, M., Serfaty, L. & Capeau, J. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management. Curr. Opin. Infect. Dis. 25, 10–16 (2012).

    Article  Google Scholar 

Download references


M.B.B. is supported by the NIH grant 5R01DK108364.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Meena B. Bansal.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chamroonkul, N., Bansal, M.B. HIV and the liver. Nat Rev Gastroenterol Hepatol 16, 1–2 (2019).

Download citation

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing